Comunicación

Publicaciones

Volver

Global Smart Update 18: Non-medical use of benzodiazepines: a growing threat to public health?

Global Smart Update 18: Non-medical use of  benzodiazepines: a growing threat to public health?

Publicado el 20/09/18

Non-medical use of prescription benzodiazepines has been a long-established problem that has been associated with a large number of overdose deaths worldwide.  Most recently, the concomitant use of benzodiazepines and opioids has been linked to a number of deaths that occurred in the recent opioid crisis, featuring in a rising number of fatalities and adverse events in  North  America and in Europe. In recent years, several new psychoactive substances (NPS) belonging to the benzodiazepine class have also emerged on the market and are being sold under street names such as “legal benzodiazepines”, “designer benzodiazepines”, and “research chemicals”. The use of such NPS belonging to the benzodiazepine class and the non-medical use of pharmaceutical benzodiazepines pose a great threat to public health.

Acceder en inglés

Próximas actividades

  • 3ª Semana Anual de Precursores

    Reducción de la Oferta de Drogas

    12/11/18 - 15/11/18

    Lisboa, Portugal

  • 2ª Reunión para la validación de los criterios básicos y avanzados de calidad y basados en la evidencia para programas de tratamiento y prevención

    Reducción de la Demanda de Drogas

    20/11/18 - 22/11/18

    Santiago, Chile

Ver todas las actividades